Appili Therapeutics Inc. APLIF
0.01 USD 0.00 0.00%
At close · Oct 30
- YTD
- -53.33%
- 1 year
- -53.33%
- Open
- 0.004
- Prev close
- 0.007
- Mkt cap
- 926.56K
- Vol
- 36.65K
- Avg vol
- 5.49K
- EPS
- -0.03
- P/E
- 0.00
More statistics
- Low
- 0.004
- High
- 0.0068
- Earnings
- Feb 11, 2025
MAX chart
Chart tools
Chart is warming up
The all-time price history for APLIF has not been loaded yet. Try again in a moment.
Altman Z-Score
-115.59 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 4
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
P/E -0.4×
P/S 7.7×
P/B -0.1×
P/FCF -1.4×
EV/EBITDA -2.3×
EV/Sales 60.6×
FCF Yield -73.3%
Gross Margin 96.7%
Operating Margin -2675.6%
Net Margin -1736.7%
ROE 24.5%
ROIC 148.6%
ROA -214.9%
Revenue 143.7%
Operating Income -3332.3%
EPS (diluted) -59.3%
Free Cash Flow -260.2%
Current Ratio 0.1×
Quick Ratio 0.1×
Debt / Equity -0.7×
Net Debt / EBITDA -2.0×
Interest Coverage -6.4×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-03-31